Help
RSS
API
Feed
Maltego
Contact
Domain > www.biosimilaariopas.fi
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2023-09-20
34.232.23.254
(
ClassC
)
2024-11-25
20.119.128.11
(
ClassC
)
2025-12-07
147.79.120.38
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyContent-Length: 155Content-Type: text/html; charsetutf-8Date: Mon, 25 Nov 2024 02:26:26 GMTAccess-Control-Allow-Headers: Origin, X-Requested-With, Content-Type, AcceptAcc head>title>Document Moved/title>/head>body>h1>Object Moved/h1>This document may be found a HREFhttps://www.biosimilaariopas.fi/>here/a>/body>
Port 443
HTTP/1.1 200 OKContent-Length: 15780Content-Type: text/html; charsetutf-8Date: Mon, 25 Nov 2024 02:26:27 GMTAccess-Control-Allow-Headers: Origin, X-Requested-With, Content-Type, AcceptAccess-Control-A !DOCTYPE html>!--if lt IE 7> html classno-js lt-ie9 lt-ie8 lt-ie7> !endif-->!--if IE 7> html classno-js lt-ie9 lt-ie8> !endif-->!--if IE 8> html classno-js lt-ie9> !endif-->!--if gt IE 8>!-->html classno-js langfi-FI>!--!endif-->head>link hrefhttps://mc-309d00c8-1c0d-4bd3-bd41-6393-cdn-endpoint.azureedge.net/-/media/Feature/Experience-Accelerator/Bootstrap-5/Bootstrap-5/Styles/optimized-min.css?rev-1&t&hash67B6B246DB62E91CAE116685822F66CD relstylesheet>link hrefhttps://mc-309d00c8-1c0d-4bd3-bd41-6393-cdn-endpoint.azureedge.net/-/media/Themes/Biocon/BiosimilarsFIN/BiosimilarsFIN/styles/font-style-PROD.css?rev-1&hash9A991F1EC24EE5B9F60724E43555F86A relstylesheet>link hrefhttps://mc-309d00c8-1c0d-4bd3-bd41-6393-cdn-endpoint.azureedge.net/-/media/Themes/Biocon/BiosimilarsFIN/BiosimilarsFIN/styles/home.css?rev-1&hashDF614379637BC4D5B82E73C234F01991 relstylesheet>link hrefhttps://mc-309d00c8-1c0d-4bd3-bd41-6393-cdn-endpoint.azureedge.net/-/media/Themes/Biocon/BiosimilarsFIN/BiosimilarsFIN/styles/style-8.css?reve4b5035fb35f4fd6a160d15df19bcafa&hash7D5B9FB62CA47BA0363D6EEDECABBD47 relstylesheet>link hrefhttps://mc-309d00c8-1c0d-4bd3-bd41-6393-cdn-endpoint.azureedge.net/-/media/Themes/Biocon/BiosimilarsFIN/BiosimilarsFIN/styles/custom-validation.css?rev-1&hashDB49236D907A990CDB1F5CD2877CCC19 relstylesheet>link hrefhttps://mc-309d00c8-1c0d-4bd3-bd41-6393-cdn-endpoint.azureedge.net/-/media/Themes/Biocon/BiosimilarsFIN/BiosimilarsFIN/styles/header.css?revd87656478f404cacb498adc8d8f2191b&hash2C410CF81868E43E7356DB603AA4E42F relstylesheet>link hrefhttps://mc-309d00c8-1c0d-4bd3-bd41-6393-cdn-endpoint.azureedge.net/-/media/Themes/Biocon/BiosimilarsFIN/BiosimilarsFIN/styles/popup.css?rev342389020de54c69b1472bac0b5fab4f&hashA22BF98BFCE3B3F5260AB375D399315A relstylesheet> title>BioSimilaariopas.fi/title>link relcanonical hrefhttps://biosimilaariopas.fi> link href/-/media/Project/Biocon/shared/favicon/favicon.svg?rev-1 relshortcut icon />meta propertyog:description contentTervetuloa Biosimilaariop
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]